Abundant immunohistochemical expression of dopamine D-2 receptor and p53 protein in meningiomas: follow-up, relation to gender, age, tumor grade, and recurrence

作者：Trott G^*; Pereira Lima J F S; Leaes C G S; Ferreira N P; Barbosa Coutinho L M; Oliveira M C

来源：Brazilian Journal of Medical and Biological Research, 2015, 48(5): 415-419.

DOI：10.1590/1414-431X20144163

• Receptors
• Dopamine D-2
• Immunohistochemistry
• Meningioma
• Tumor suppressor protein p53
• Recurrence

Meningiomas are common, usually benign tumors, with a high postoperative recurrence rate. However, the genesis and development of these tumors remain controversial. We aimed to investigate the presence and implications of a mutated p53 protein and dopamine D-2 receptor in a representative series of meningiomas and to correlate these findings with age, gender, tumor grade, and recurrence. Tumor tissue samples of 157 patients diagnosed with meningioma (37 males and 120 females, mean age 53.6 +/- 14.3 years) who underwent surgical resection between 2003 and 2012 at our institution were immunohistochemically evaluated for the presence of p53 protein and dopamine D-2 receptor and were followed-up to analyze tumor recurrence or regrowth. Tumors were classified as grades I (n=141, 89.8%), II (n=13, 8.3%), or grade III (n=3, 1.9%). Dopamine D-2 receptor and p53 protein expression were positive in 93.6% and 49.7% of the cases, respectively. Neither of the markers showed significant expression differences among different tumor grades or recurrence or regrowth statuses. Our findings highlight the potential role of p53 protein in meningioma development and/or progression. The high positivity of dopamine D-2 receptor observed in this study warrants further investigation of the therapeutic potential of dopamine agonists in the evolution of meningiomas.

• 出版日期2015-5